These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23621126)

  • 21. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
    Xue Y; Abou Tayoun AN; Abo KM; Pipas JM; Gordon SR; Gardner TB; Barth RJ; Suriawinata AA; Tsongalis GJ
    Cancer Genet; 2013 Jun; 206(6):217-21. PubMed ID: 23933230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA gene polymorphisms in pancreatic cancer.
    Pavlakis E; Papaconstantinou I; Gazouli M; Theodosopoulos T; Karamanolis G; Genatas K; Ladas SD
    Pancreatology; 2013; 13(3):273-8. PubMed ID: 23719600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. microRNAs in the Malignant Transformation Process.
    Sarver AE; Li L; Kartha RV; Subramanian S
    Adv Exp Med Biol; 2015; 889():1-21. PubMed ID: 26658993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.
    Mueller DW; Bosserhoff AK
    Int J Cancer; 2011 Sep; 129(5):1064-74. PubMed ID: 21077158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging roles of miRNAs in the development of pancreatic cancer.
    Fathi M; Ghafouri-Fard S; Abak A; Taheri M
    Biomed Pharmacother; 2021 Sep; 141():111914. PubMed ID: 34328099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.
    Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA
    Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [miRNA-192, miRNA-21 and miRNA-200: new pancreatic cancer markers in diabetic patients?].
    Škrha P; Hořínek A; Anděl M; Škrha J
    Vnitr Lek; 2015 Apr; 61(4):351-4. PubMed ID: 25894267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New combined microRNA and protein plasmatic biomarker panel for pancreatic cancer.
    Yuan W; Tang W; Xie Y; Wang S; Chen Y; Qi J; Qiao Y; Ma J
    Oncotarget; 2016 Nov; 7(48):80033-80045. PubMed ID: 27713117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators.
    Daoud AZ; Mulholland EJ; Cole G; McCarthy HO
    BMC Cancer; 2019 Nov; 19(1):1130. PubMed ID: 31752758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insights into the Role of microRNAs in Pancreatic Cancer Pathogenesis: Potential for Diagnosis, Prognosis, and Therapy.
    Khan MA; Zubair H; Srivastava SK; Singh S; Singh AP
    Adv Exp Med Biol; 2015; 889():71-87. PubMed ID: 26658997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis.
    Nakata K; Ohuchida K; Mizumoto K; Kayashima T; Ikenaga N; Sakai H; Lin C; Fujita H; Otsuka T; Aishima S; Nagai E; Oda Y; Tanaka M
    Surgery; 2011 Nov; 150(5):916-22. PubMed ID: 22018284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [MicroRNA in Various Aspects of Cancer Development].
    Nambara S; Mimori K
    Gan To Kagaku Ryoho; 2017 May; 44(5):362-366. PubMed ID: 28536328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of circulating microRNAs as diagnostic biomarkers in colorectal cancer.
    Clancy C; Joyce MR; Kerin MJ
    Cancer Biomark; 2015; 15(2):103-13. PubMed ID: 25547322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical implication of microrna for lung cancer.
    Wang Y; Zhang X; Liu L; Li H; Yu J; Wang C; Ren X
    Cancer Biother Radiopharm; 2013 May; 28(4):261-7. PubMed ID: 23496233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
    Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
    Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development.
    Zhang S; Hao J; Xie F; Hu X; Liu C; Tong J; Zhou J; Wu J; Shao C
    Carcinogenesis; 2011 Aug; 32(8):1183-9. PubMed ID: 21665894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting miRNAs for pancreatic cancer therapy.
    Shi M; Xie D; Gaod Y; Xie K
    Curr Pharm Des; 2014; 20(33):5279-86. PubMed ID: 24479803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA Targeted Therapeutic Approach for Pancreatic Cancer.
    Li Y; Sarkar FH
    Int J Biol Sci; 2016; 12(3):326-37. PubMed ID: 26929739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers.
    Powrózek T; Krawczyk P; Kowalski DM; Winiarczyk K; Olszyna-Serementa M; Milanowski J
    Transl Res; 2015 Oct; 166(4):315-23. PubMed ID: 26079400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer.
    He H; Di Y; Liang M; Yang F; Yao L; Hao S; Li J; Jiang Y; Jin C; Fu D
    Oncol Rep; 2013 Aug; 30(2):651-8. PubMed ID: 23733161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.